Pregaba Capsule 75 mg (Pregabalin)

Adult dose

This medication should be taken orally, divided into two doses per day, regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: The starting dose is 150 mg once daily, which may be increased to 300 mg within 3 to 7 days, and if necessary, may be further increased to a maximum of 600 mg per day at 7-day intervals. - Central neuropathic pain: The starting dose is 150 mg once daily, which may be increased to 300 mg after one week.

Child dose

There is insufficient safety and efficacy data for patients under 12 years of age and adolescents aged 12-17, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or actions, so if symptoms of depression or mood changes occur during use, it is important to consult a doctor immediately. Patients who have allergies to any of the ingredients in this medication or certain genetic disorders should not use it. Diabetic patients should be cautious, as weight gain may necessitate adjustments in antidiabetic medication dosages. If allergic reactions such as angioedema occur, the medication should be discontinued immediately, and healthcare personnel should be informed. Elderly patients may be at risk of falling due to dizziness or drowsiness, and if such symptoms occur, they should consult with a healthcare provider. Vision disturbances or changes in sight may occur, so it is essential to report any eye issues immediately. Discontinuing this medication suddenly may lead to withdrawal symptoms like insomnia, headache, nausea, and anxiety; therefore, it should be tapered off according to the physician's instructions. Due to the risk of drug abuse, patients with a history of mental illness or substance abuse should be observed more closely. Patients with reduced kidney function may require dosage adjustments. Patients with heart disease should be cautious when taking this medication; if symptoms of heart failure occur, they must consult healthcare personnel immediately. Taking this medication with other central nervous system depressants or opioids may increase the risk of respiratory depression, so caution is necessary when used together. In early pregnancy, there is a risk of fetal malformation; thus, women who are pregnant or planning to get pregnant must consult a doctor and use effective contraceptive methods. Breastfeeding women should consult a physician regarding the potential transfer of the medication into breast milk and whether to discontinue breastfeeding or the medication. While driving or operating machinery, caution is needed due to the risk of accidents from dizziness and drowsiness until symptoms are fully assessed. Overdosage may result in symptoms such as confusion, drowsiness, and depression; therefore, the prescribed dosage must be strictly followed, and in the event of an overdose, immediate medical attention is required. Keep this medication out of the reach of children, and do not transfer it to another container for safety. If serious adverse reactions like skin rash, fever, or difficulty breathing occur while taking this medication, discontinue use immediately and seek emergency medical treatment.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

Dizziness, drowsiness, confusion, disturbances in spatial orientation, irritability, depression, euphoria, reduced libido, insomnia, depersonalization, sexual hypersensitivity, restlessness, anxiety, mood fluctuations, emotional blunting, emotional elevation, difficulties in finding appropriate words, hallucinations, abnormal dreams, increased sexual desire, panic attacks, impulsivity, apathy, ataxia, motor coordination disturbances, balance disorders, amnesia, attention deficits, memory disturbances, tremors, speech disturbances, sensory disturbances, reduced sensation

This medication should be stored in a closed container to protect it from exposure to air or moisture, ideally at room temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part, containing white powder

Package unit

(For domestic use) 30 capsules/bottle, 100 capsules/bottle (For export) 30 capsules (10 capsules x 3 PTP)